Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Determining the Risk of Fetal Loss in Women With Unprovoked Venous Thromboembolism (VTE) Who Do NOT Have Identifiable Inherited Thrombophilia Compared With Women Who Have the Diagnosis of VTE Excluded
Sponsor: Canadian Institutes of Health Research (CIHR)
Terminated
Funding withdrawn due to low enrollment
Other terminated trials from Canadian Institutes of Health Research (CIHR)
- Copd · Phase PHASE2/PHASE3 · Feb 2026
- Insomnia · Phase NA · Dec 2024
- X Linked Myotubular Myopathy · Phase PHASE1/PHASE2 · May 2024
- Autism Spectrum Disorder · Phase NA · May 2023
- Age-related Macular Degeneration · Phase NA · Mar 2023
See all terminations from Canadian Institutes of Health Research (CIHR)
Other Fetal Death trials with similar outcome
Listed as NCT00149357, this observational or N/A phase trial focuses on Fetal Death and Venous Thromboembolism and remains terminated or withdrawn. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 2 earlier versions
-
Apr 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Apr 2017 [monthly]
Terminated NA
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- McMaster University
For direct contact, visit the study record on ClinicalTrials.gov .